| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Thermo Fisher Launches SuperScript V Reverse Transcriptase | 8 | Contract Pharma | ||
| Di | Dividendenbekanntmachungen (15.09.2026) | 8.938 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| THERMO FISHER SCIENTIFIC INC CDR Aktie jetzt für 0€ handeln | |||||
| 09.09. | Wachstumsausblick überzeugt: UBS stuft Thermo Fisher Scientific auf "Kaufen" hoch | 43 | Investing.com Deutsch | ||
| 09.09. | UBS upgrades Thermo Fisher Scientific stock rating on growth outlook | 24 | Investing.com | ||
| 08.09. | If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today | 5 | Benzinga.com | ||
| 08.09. | Baron Durable Advantage Fund initiates Arxis, exits Intuit and Thermo Fisher among Q2 moves | 21 | Seeking Alpha | ||
| 03.09. | CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc, WUXI APPTEC | 3 | AASTOCKS | ||
| 31.08. | Is Thermo Fisher Scientific Stock Outperforming the Nasdaq? | 10 | Barchart.com | ||
| 24.08. | Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? | 12 | Insider Monkey | ||
| 24.08. | Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable? | 10 | Insider Monkey | ||
| 24.08. | Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery? | 20 | Insider Monkey | ||
| 17.08. | Thermo Fisher Scientific Stock: Analyst Estimates & Ratings | 13 | Barchart.com | ||
| 13.08. | Astorg schließt die Übernahme des Mikrobiologiegeschäfts von Thermo Fisher Scientific ab | 32 | Bionity.com | ||
| 12.08. | Astorg Acquires Thermo Fisher Microbiology Business for $1.075B | 6 | Contract Pharma | ||
| 12.08. | Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist | 1.499 | Business Wire | The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and... ► Artikel lesen | |
| 12.08. | Thermo Fisher Scientific Inc.: Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg | 1.141 | Business Wire | Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private... ► Artikel lesen | |
| 12.08. | Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)? | 12 | Insider Monkey | ||
| 11.08. | $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today | 10 | Benzinga.com | ||
| 11.08. | Thermo Fisher Says India Is One Of Its Fastest-Growing Markets | 6 | Benzinga.com | ||
| 11.08. | Abbott vs. Thermo Fisher: Is Diversification or the Life Sciences Recovery the Better Bet? | 11 | Insider Monkey |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| THERMO FISHER | 572,80 | +1,31 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,950 | -2,70 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| AETHLON MEDICAL | 7,190 | +402,80 % | Morning Market Movers: Aethlon Medical, CID HoldCo, Longeveron, Delixy See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,270 | +6,43 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| FRESENIUS | 45,900 | -0,52 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,520 | +0,42 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| BETA BIONICS | 21,010 | -5,28 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,95 | -0,02 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 102,02 | +4,66 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 29,300 | -3,30 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,110 | -1,05 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| LIFESTANCE HEALTH GROUP | 12,950 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| ESSILORLUXOTTICA | 141,40 | -2,78 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| HEARTFLOW | 49,140 | +1,68 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| NUWELLIS, INC | 1,050 | +28,83 % | Nuwellis, Inc.: Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs | MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced... ► Artikel lesen |